Journal of Clinical and Translational Hepatology · 2017 · 15 citations · 12 references
PharmacyNephrologyPharmacotherapyDialysisHemodialysisVirologyAntiviral TherapyInterferon-based TherapyRenal DiseaseTreatment DurationViral HepatitisViral Hepatitis TreatmentChronic Viral HepatitisDirect-acting Antiviral AgentsDirect-acting AntiviralsNucleoside Analogue AntiviralsProspective Antiviral De-escalationSustained Virologic Response DurationTreatment Adverse EffectsViral Load Assessment
Background and Aims: Patients with chronic hepatitis C (CHC) and end-stage renal disease (ESRD) who are dialysis-dependent form a unique group, in which safety, tolerability and efficacy of sofosbuvir (SOF)-based direct-acting antivirals (DAAs) need further evaluation.
12
David Roth, David R. Nelson, Annette Bruchfeld et al. · The Lancet · 2015 · 666 citations · Full text